Medtronic offers technology that can make a difference for you now and in the future. Once you’ve made the decision to get DBS Therapy, your doctor will help you decide which system is right for you.
Medtronic DBS systems include:
Treatment as unique as you
Discover the sensing-enabled Recharge-free DBS system
Now you're in charge
Explore the 15-year Rechargeable DBS System that's designed to fit around your life.
ACTIVA™ RC FEATURES
DECADES OF DBS THERAPY EXPERIENCE.
As a global leader in medical technology, we continually seek ways to improve the lives of people. Development of DBS Therapy started in 1987 and Medtronic has been a leader in the field ever since. Medtronic DBS Therapy for Tremor Control was approved by the U.S. Food and Drug Administration in 1997.
LEADERS IN MRI ACCESSIBILITY FOR DBS PATIENTS
Approximately seven out of ten DBS-eligible patients with movement disorders may need an MRI within ten years of receiving their device.1
This is why we developed the first full-body MR Conditional† DBS system — which gives you access to this important diagnostic imaging tool should you need it in the future.
A COMPLETE SYSTEM THAT BRINGS COMPLETE BENEFITS
With a complete Medtronic system — lead, extension, and neurostimulator — you get:
Signal may not be present or measurable in all patients. Clinical benefits of brain sensing have not been established.
Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If these conditions are not met, there is a significant risk of tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury, including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions: http://professional.medtronic.com/mri.
Activa™ RC devices eligible for the service life extension and the supplemental limited warranty are those devices sold in the US that have been successfully interrogated with the Medtronic Activa™ Clinician Programmer prior to reaching End of Service (EOS). For additional information, contact email@example.com.
Falowski, S, Safriel Y, Ryan, M et al. The Rate of Magnetic Resonance Imaging in Patients with Deep Brain Stimulation. Stereotactic and Functional Neurosurgery. 2016; 94:147–153.